Condition
s100b
Total Trials
5
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Recruiting3
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07093723CompletedPrimary
Protein S100B Versus Neutrophils/Lymphocytes Ratio in Early Prediction of Brain Injury
NCT06998381RecruitingPrimary
Ethnic Specificities of S100B Protein Blood Level in Guadeloupe: Cross-sectional Study in Healthy Subjects
NCT06984445RecruitingPrimary
Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia
NCT06893926RecruitingPrimary
Cord Blood S100B Protein Concentration in Neonates With Fetal Growth Restriction
NCT00866489Phase 1CompletedPrimary
The Neuroprotective Effects of RPC on the Neurosurgery
Showing all 5 trials